Norges Bank’s Cabaletta Bio CABA Stock Holding History

Norges Bank’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47,100	Closed	-$344K	–	2080
2020 Q1	$344K	Sell	47,100 -17,900	-28%	-$245K	﹤0.01%	2022
2019 Q4	$908K	Buy	+65,000	New	+$770K	﹤0.01%	2029

Other funds holding CABA

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank's CABA Position: Q2 2020 in Review

Norges Bank sold out of Cabaletta Bio (CABA) in Q2 2020, closing a stake of 47,100 shares — an estimated $344K sold.

Norges Bank first reported a position in CABA in Q4 2019 and held it in 2 quarters. The position peaked at $908K in Q4 2019. 52 funds tracked by Wall St. Rank hold CABA as of Q2 2020.

Norges Bank reported no remaining Cabaletta Bio position as of Q2 2020 after selling out during the quarter.
Norges Bank sold 47,100 Cabaletta Bio shares in Q2 2020, an estimated $344K.
Norges Bank first reported a position in Cabaletta Bio in Q4 2019 and held it in 2 quarters.
Norges Bank's Cabaletta Bio position peaked at $908K in Q4 2019.
52 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2020.

Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.